Tag: technology

Good morning! Today, there is a lot of news from the American Heart Association's annual meeting, and former National Cancer Institute chief Ned Sharpless has launched a new biotech company called Jupiter. Here's what you...

Good day to you! The Pharmalot team is here, ready to dive into the latest news in the pharmaceutical world. Today, we have some interesting updates to share with you, so grab a cup...

Good day, and thank you for allowing me to share some interesting insights with you. I'm still active on the platform previously known as Twitter, which shows that old habits die hard. It seems...

President-elect Trump has nominated Robert F. Kennedy Jr. as the country’s new health secretary, which has caused a stir in the biotech community. Kennedy is known for being a vaccine skeptic, and his appointment...

Intellia Therapeutics CEO John Leonard has been facing a familiar situation for the past few years. The company has been sharing positive results from its gene editing trials, only to see its stock prices...

Federal officials recently announced a breakthrough in telehealth prescriptions for stimulants and addiction treatment. The Drug Enforcement Agency (DEA) has extended the temporary rules that allowed health providers to prescribe drugs for opioid addiction...

Michelle Monje-Deisseroth, a medical student about 20 years ago, treated patients with a type of brain tumor called diffuse intrinsic pontine gliomas, or DIPG. These tumors are difficult to treat because they wrap around...

Generalized Pustular Psoriasis (GPP) is a skin condition that can affect individuals of any age, but it is most commonly seen in middle-aged adults, with a higher prevalence in women. The condition is characterized...

Merck, a leading pharmaceutical company, has recently taken a strategic step to enhance its cancer drug portfolio by acquiring the licensing rights for a new cancer drug from LaNova Medicines, a Chinese firm based...

Good morning, everyone, and welcome to a new week of work. We hope you had a restful weekend and are ready to dive back into the routine of online meetings and deadlines. Let's start...

23andMe, the genetics company that many people have been excited about, recently made a big announcement. The company has decided to stop working on creating new medicines and will be letting go of 40%...

As we approach the end of another workweek, it's time to start thinking about weekend plans. Our schedule includes tending to the Pharmalot grounds, spending time with our beloved mascots, and catching up on...

Biotech analyst Brian Skorney and biotech executive Daphne Zohar recently appeared on "The Readout LOUD" podcast to share their thoughts on how the outcomes of the recent election may impact the biotech industry. They...

Dear Readers,I have written to you before to talk about the importance of subscribing to STAT for our comprehensive coverage of health and medicine. Today, I feel compelled to reiterate this message as we...

Adam: Hey Matt, glad you could join me today. The future of the biotech industry post-Trump presidency is something that many are curious about. One key aspect that everyone is keeping an eye on...

A recent Senate investigation revealed that the three largest Medicare Advantage insurers in the nation, including UnitedHealth Group, Humana, and CVS Health, have been increasingly denying claims for rehabilitative care for seniors. This denial...

In recent years, the mental health sector has experienced a transformative shift due to advancements in technology. From AI-driven diagnostic tools to virtual therapy sessions, the integration of technology in mental health treatment is...